Thrombosis Research

Article	Citations
Decreased patency of transjugular intrahepatic portosystemic shunts performed for splanchnic vein thrombosis in patients with myeloproliferative neoplasms	48
Linezolid impair proplatelet formation by reducing mitochondrial energy metabolism in MEG-01 cells	48
Major in-hospital bleeding in patients with pulmonary embolism treated with systemic thrombolysis	38
Distinct Immunologic Mediators Are Associated with Venous Thromboembolism in Multiply Injured Patients	37
Vaccine-induced immune thrombocytopenia and thrombosis after mRNA-1273 booster vaccination	36
Investigation of the impact of antithrombin deficiency on the inflammatory response: Results from a single centre cohort study	35
Unveiling the predictive capacity of inflammatory and platelet markers for central retinal artery occlusion	35
Cyclophosphamide vs rituximab for eradicating inhibitors in acquired hemophilia A: A randomized trial in 108 patients	35
Editorial Board	34
Corrigendum to “Repurposing of rilpivirine for preventing platelet β3 integrin-dependent thrombosis by targeting c-Src active autophosphorylation” [Thromb. Res. 229 (2023) 53–68]	33
Regulation of fibrinogen synthesis	32
The role of interleukin-10 gene variants in inhibitor development in hemophilia: A meta-analysis	30
Cost of immune tolerance induction according to its outcome in people with hemophilia A and inhibitors: results from the Co$tIT study	29
DOACs: A perfect fit for patients with bariatric surgery?	29
A novel role of acellular hemoglobin in hemolytic thrombosis	29
Predicting post-discharge venous thromboembolism and bleeding among medical patients: External validation of a novel risk score utilizing ubiquitous biomarkers	29
Impact of aetiology and liver stiffness on thrombin generation in compensated cirrhosis	28
Thrombosis after surgical splenectomy – why, in whom and can we prevent it?	26
The maternal hemostatic shift: Understanding VTE risk in pregnancy and postpartum	26
Rivaroxaban plus aspirin versus acenocoumarol to manage recurrent venous thromboembolic events despite systemic anticoagulation with rivaroxaban	26
Assessing the risk of venous thromboembolism in trans masculine persons on gender-affirming hormone therapy: A literature review	25
Acute and subacute effects of strenuous exercise on platelet aggregation, coagulation and fibrinolysis in patients with stable coronary artery disease	25
Main features of ischemic stroke in patients with acute immune-mediated thrombotic thrombocytopenic purpura	24
Treatment strategies, bleeding, long-term recurrence and mortality in abdominal vein thrombosis: Findings from the TROLL registry	24
Myocardial ischemia-reperfusion injury released cellular fibronectin containing domain A (CFN-EDA): A destructive positive loop amplifying arterial thrombosis formation and exacerbating myocardial rep	24

Clinical outcomes of cancer-associated isolated superficial vein thrombosis in daily practice	24
Is all collagen the same for platelet testing? Editorial on “Platelet collagen receptors and their role in modulating platelet adhesion patterns and activation on alternatively processed collagen subs	24
Prosthetic valve dysfunction in patients with mechanical heart valves: Results from the Emergency Salam Centre cohort	24
Venous thromboembolism in hematopoietic stem cell transplantation: A narrative review	23
Driver gene KRAS aggravates cancer-associated stroke outcomes	23
Real-time risk stratification in acute pulmonary embolism: the utility of RV/LV diameter ratio	23
Sex disparities of clinical manifestations in acute pulmonary embolism and predictive value for in-hospital mortality: Insights from CURES	22
Pulmonary embolism bleeding score index (PEBSI): A new tool for the detection of patients with low risk for major bleeding on thrombolytic therapy	22
Canadian Perspective on Superficial Vein Thrombosis in Pregnancy and Postpartum: Interim Results from a Tertiary Care Centre	22
A comprehensive review of the autoimmune pathogenesis of acquired hemophilia A	21
Predicting functional outcomes after acute ischemic stroke – Is thrombelastography useful outside perioperative bleeding management?	21
D-dimer as a predictive biomarker for cancer-associated thrombosis: A prospective cohort study	21
Editorial Board	20
Intrinsic coagulant potential modulates anticoagulant efficacy of rivaroxaban	20
A survey on clinical practice in monitoring and management of bleeding in children with haemophilia A on emicizumab prophylaxis in the PedNet centres	20
Identification of phenotypes and predictors for dyspnea, echocardiographic probability of pulmonary hypertension, and confirmed CTEPH in patients with acute pulmonary embolism: Analysis of two large p	20
D-dimer and risk of venous thromboembolism recurrence: Comparison of two studies with similar designs but different laboratory and clinical results	20
Letter to the editor regarding the article “Platelet activity, coagulation, and fibrinolysis in long-term users of anabolic-androgenic steroids compared to strength-trained athletes”	20
Control of warfarin treatment in patients with antiphospholipid syndrome and falsely high INR at point-of-care-testing	20
Isolated subsegmental pulmonary embolism identification based on international classification of diseases (ICD)-10 codes and imaging reports	20
Safety of fixed-dose heparin titration boluses in underweight patients	20
Don't let D-dimer fool you: Elevated D-dimer plasma levels should not imply ‘hyperfibrinolysis’	20
In vitro procoagulant effects of Gla-domainless factor Xa in factor XI-deficient and factor IX-deficient plasma	20
Association between neutrophil extracellular traps (NETs) and thrombosis in antiphospholipid syndrome	20
Statin use and mortality in patients with deep vein thrombosis. Data from the RIETE Registry	19
Comparison of absolute immature platelet count to the PLASMIC score at presentation in predicting ADAMTS13 deficiency in suspected thrombotic thrombocytopenic purpura	19
Large deletions and small insertions and deletions in the factor VIII gene predict unfavorable immune tolerance induction outcome in people with severe hemophilia A and high-responding inhibitors	19
To aPTT or not to aPTT: Evaluating the optimal monitoring strategy for unfractionated heparin	19
Changes in haemostasis and inflammatory markers after mRNA BNT162b2 and vector Ad26.CoV2.S SARS-CoV-2 vaccination	18
Rivaroxaban for pediatric venous thromboembolism in routine clinical practice: Effectiveness and safety from a real-world cohort	18
Editorial Board	18
The role of platelets in heat-related illness and heat-induced coagulopathy	18
CT coronary calcium score is a prognostic marker in acute pulmonary embolism	18
Editorial Board	18
Risk factors for thrombocytopenia in adult patients with sepsis: A systematic review and meta-analysis	18
Rotational thromboelastometry as a biomarker for mortality — The Maastricht Intensive Care COVID cohort	17
Evaluation of modified pediatric sepsis-induced coagulopathy score in pediatric septic shock	17
Thromboelastography as a predictor of functional outcome in acute ischemic stroke patients undergoing endovascular treatment	17
Pulmonary embolism diagnostic strategies in patients with COPD exacerbation: Post-hoc analysis of the PEP trial	17
The long haul COVID-19 arterial thrombosis	17
A noncanonical splicing variant c.875-5 T > G in von Willebrand factor causes in-frame exon skipping and type 2A von Willebrand disease	17
Regulation of coagulation activation in newly diagnosed AML by the heme enzyme myeloperoxidase	17
Optimizing therapeutic enoxaparin in preterm neonates and infants	17
SSA-sMLP: A venous thromboembolism risk prediction model using separable self-attention and spatial-shift multilayer perceptrons	17
Safety and effectiveness of statins in hospitalized patients with COVID-19: Systematic review and collaborative meta-analysis of randomized controlled trials	17
Abstracts from the CanVECTOR 2024 Annual Conference October 25th, 2024	17
Association between the simplified Pulmonary Embolism Severity Index (sPESI) score and hospitalization in emergency department patients diagnosed with pulmonary embolism	17
Barriers and facilitators for adherence to direct oral anticoagulants in patients with atrial fibrillation: A qualitative approach	16
Stroke mortality in cancer survivors: A population-based study in Japan	16
Suitability and readiness assessment of organizational resources for the implementation of gene therapy in hemophilia in Spain and Portugal: A survey-based study	16

Accuracy of physical examination in detecting central venous catheter-associated thrombosis in critically ill children	16
Monitoring the Hemostatic Balance: measuring thrombin generation in a patient with acquired hemophilia A on combined pro- and anticoagulant therapy	16
Low-dose immune tolerance induction therapy in severe hemophilia a children in China: Starting earlier resulted in better inhibitor eradication outcomes	16
Thrombin generation assay in venous thromboembolism: A scoping review	16
Mental, emotional and social dimensions of quality of life and their relationship with physical and functional status in adults with haemophilia	16
Intracoronary antithrombotic therapy during primary percutaneous coronary intervention in patients with STEMI: A systematic review and network meta-analysis	15
Atrial fibrillation and peripheral arterial disease define MPN patients with very high risk of thrombosis	15
A Predictive Model to Identify Pulmonary Embolism in Unselected Emergency Department Patients: Model Validation and Improvement During the COVID Era	15
Incidence and impact of venous thromboembolism in hospitalized patients with Crohn's disease	15
Postoperative myocardial injury and platelet reactivity in patients undergoing vascular surgery: The platelet reactivity and postoperative myocardial injury after major vascular surgery (PROMISE) stud	15
Procoagulant phenotype induced by oxidized high-density lipoprotein associates with acute kidney injury and death	15
Risk of venous thromboembolism in women with endometriosis	15
Effect of lupus anti-coagulant and antiphospholipid antibodies on clot waveform analysis parameters	15
Clinical and economic burden of immune tolerance induction in entire patients with hemophilia A: Insights from a real-world Korean setting	15
Performance of age-adjusted and fixed threshold D-dimer to exclude DVT in those with low pre-test probability – Single centre experience	15
Editorial Board	15
Anticoagulation plus antiplatelet therapy versus anticoagulation alone following iliac vein stent implantation in acute and subacute deep vein thrombosis: A multicenter study with propensity score mat	15
Extracellular histones promote retraction and impair lysability of platelet-rich clots	15
Protein disulfide isomerase 1 (PDIA1) regulates platelet-derived extracellular vesicle release	15
Critique and advice of a multicenter mechanical thrombectomy registry in intermediate-risk PE	14
Risk factors for hospital acquired venous thromboembolism in congenital heart disease patients: A report from the children's hospital acquired thrombosis (CHAT) consortium	14
Recurrent mechanical prosthetic valve thrombosis: Another clinical challenge	14
The role of platelets in the regulation of myeloid-derived suppressor cells in immune thrombocytopenia	14
The influence of metastasis on clinical outcomes in patients with cancer-associated isolated distal deep vein thrombosis: A pre-specified subgroup analysis from the ONCO DVT study	14
ROS-driven structural and functional fibrinogen modifications are reverted by interleukin-6 inhibition in Giant Cell Arteritis	14
Elevated plasma levels of factor VIII enhance arterial thrombus formation on erosive smooth muscle cell-rich neointima but not normal intima in rabbits	14
Long-term recurrence, bleeding, and mortality after first-time subsegmental pulmonary embolism compared to more proximal pulmonary embolism: Findings from the TROLL registry	14
Thrombocytopenia is associated with a dysregulated host response in severe COVID-19	14
The Attend-PE model: A feasibility study of a structured follow-up care model for patients with pulmonary embolism.	14
Trends in ischemic heart disease and thromboembolism-related mortality in the United States, 1999–2024: A population-based analysis using CDC WONDER Data	14
Outcomes of IVF treatments in women with antiphospholipid antibodies or antiphospholipid syndrome	13
Identification of two de novo variants causing inherited antithrombin deficiency by quantitative analysis of variant alleles	13
A novel F7 mutation (p.Gly217Arg) associated with infantile intracranial hemorrhage successfully managed with rFVIIa	13
Low recurrent thrombosis rates in single positive antiphospholipid syndrome regardless of type of anticoagulation	13
DOACs plasma levels in relation to clinical outcome. How far have we come?	13
The course of pulmonary embolism in individuals recovered from COVID-19	13
The safety of direct oral anticoagulants use during lactation: A systematic review	13
Trends of hospital admissions due to acute limb ischemia and venous thromboembolism in Austria: A population-wide observational analysis from 2009 to 2023	13
Editorial Board	13
Prolonged D-dimer elevation after COVID-19: diagnostic noise or residual risk in suspected pulmonary embolism?	13
Risks of bleeding and thromboembolic events in patients undergoing colonoscopy on uninterrupted and interrupted anticoagulant therapy in real-world setting	13
Platelets provide robustness of spatial blood coagulation to the variation of initial conditions	13
A systematic review and meta-analysis of periprocedural bridging for patients with mechanical heart valves undergoing non-cardiac interventions	13
In Memory of Dr. Jeffrey Ginsberg	12
Increased contact system activity three months after starting combined oral contraceptives	12
Enoxaparin for outpatients with COVID-19: 90-day results from the randomised, open-label, parallel-group, multinational, phase III OVID trial	12
The contact system in chronic kidney disease and hemodialysis – A cross-sectional study	12
Venous thromboembolism in women with hormone-dependent breast cancer. To continue or discontinue hormonal treatment? Insights from the RIETE registry	12
Association between coagulation activity and clinical and imaging outcomes in acute ischemic stroke patients - A sub-study of the MR CLEAN NO-IV trial	12
Air pollution impacts on in-hospital case-fatality rate of ischemic stroke patients	12
Thymidine phosphorylase mediates SARS-CoV-2 spike protein enhanced thrombosis in K18-hACE2TG mice	12
Perioperative factor XIII and viscoelastic measurements of open compared to minimal invasive major upper gastrointestinal surgery– A prospective observational study	12
Changes in right ventricular function in patients with acute pulmonary thromboembolism as assessed by transthoracic echocardiography: A one-year follow-up study	12
Hemostatic considerations for gender affirming care	12
Performance of the 4-Level Pulmonary Embolism Clinical Probability Score (4PEPS) in the diagnostic management of pulmonary embolism: An external validation study	12
Characteristics and outcome of a territory-wide cohort study of patients with acquired hemophilia A in Hong Kong	12
Mechanisms of cerebral venous sinus thrombosis due to essential thrombocythemia: Current status and future perspectives	12
Patient characteristics, treatment patterns, and clinical outcomes in patients hospitalized with factor Xa inhibitor-associated major bleeds: A report from the REVERXaL study	12
Machine learning prediction of venous thromboembolism after surgeries of major sellar region tumors	12
Treating the mind and body: implementation of a psychosocial wellbeing assessment in the deep vein thrombosis clinic	12
DOAC Score for prediction of major bleeding in patients with venous thromboembolism: Findings from the RIETE registry	11
Identification of hematuria with a natural language processing model and validation of hematuria diagnosecodes	11
Erythrocyte rheology is altered in haemophilia patients with advanced arthropathy. A case-control study	11
Editorial Board	11
Prognostic value of an automated thrombin generation assay in COVID-19 patients entering hospital: A multicentric, prospective observational study	11
Added IMPACT: The first successful natural birth using certolizumab in obstetric APS	11
Differential regulation of human thrombospondin-1 upon systemic desmopressin versus endotoxin challenge	11
Who are we bridging? Description of warfarin patients receiving injectable bridging therapy	11
Long-term clinical outcomes in older patients with acute venous thromboembolism who have renal impairment	11
Adjusted global antiphospholipid syndrome score (aGAPSS) is useful to predict relapses in patients with retinal vein occlusion	11
Incidence and risk factors of post-thrombotic syndrome in patients with isolated calf vein thrombosis. Findings from the GARFIELD-VTE registry	11
Management strategies and clinical outcomes of venous thromboembolism in patients with antiphospholipid syndrome in the direct oral anticoagulant era: Insight from the COMMAND VTE Registry-2	11
Perinatal stroke and hypofibrinogenemia: Is the new missense fibrinogen variant γ p.Gly310Glu the cause of the procoagulant state?	11
CIB1 and platelet integrin αIIbβ3: Molecular mechanisms, disruption strategies and antithrombotic opportunities	11
Prognostic role of serial electrocardiographic changes in patients with acute pulmonary embolism. Data from the Italian Pulmonary Embolism Registry	11
Mitochondrial DNA copy number and its association with venous thromboembolism in patients with cancer	11
A real-world pharmacovigilance analysis of the FDA adverse event reporting system database for emicizumab	11
Interaction between LRP1 and PAI-1 in lower extremity deep venous thrombosis	10
Scoping review of current evidence on the incidence of Venous thromboembolism (VTE) in the East Asian population	10
Can edoxaban be used at extremes of bodyweight and in patients with a creatinine clearance ≥95 ml/min? – A population pharmacokinetic analysis	10

Prognosis after cerebral venous thrombosis: Mortality during initial admission and at 30 days and one year after discharge in a large Canadian population-based cohort	10
Molecular basis of clot retraction and its role in wound healing	10
CXCL13/CXCR5 axis facilitates TFH expansion and correlates with disease severity in adults with immune thrombocytopenia	10
Tigecycline-associated hypofibrinogenemia: A single center, retrospective, controlled study	10
Effect of regular exercise training on platelet function in patients with cardiovascular disease and healthy individuals: A systematic review	10
Shiga toxin down-regulates ERG protein in endothelial cells and impairs angiogenesis	10
Editorial Board	10
Understanding European patterns of deprescribing antithrombotic medication during end-of-life care in patients with cancer	10
Management of venous thromboembolism in stroke: A deep appraisal exposing discordance in guideline quality and recommendations	10
COVID-19 venous thromboembolism prophylaxis guidelines in pediatrics	10
Major cardiovascular events after COVID-19, event rates post-vaccination, antiviral or anti-inflammatory therapy, and temporal trends: Correspondence	10
Neutrophil extracellular traps formation may be involved in the association of propranolol with the development of portal vein thrombosis	10
Efficacy and safety of recombinant human soluble thrombomodulin in patients with sepsis-induced disseminated intravascular coagulation - A meta-analysis	10
Dynamics of troponins and 30-day mortality in hospitalized patients with pulmonary embolism	10
von Willebrand factor and fibrin monomer - induced septic shock coagulation typing: Clinical comparison between thrombotic thrombocytopenic purpura - like syndrome and sepsis - induced coagulopathy wi	10
Barriers and facilitators to healthy lifestyle behaviours for people living with post pulmonary embolism syndrome. A qualitative study exploring participants lived experiences	10
In-hospital outcomes of Ticagrelor versus Clopidogrel in high bleeding risk patients with acute coronary syndrome: Findings from the CCC-ACS project	10
Patient-parent perspectives in designing pediatric venous thromboembolism research: A qualitative study	10
Clinical and endoscopic findings in patients with acute gastrointestinal bleeding associated with direct oral anticoagulants: Results from a single-center prospective cohort study	10
Characterization of a prothrombotic phenotype using thrombin generation and thrombin activity in cirrhosis and portal hypertension	10
Efficacy and safety of antithrombin or recombinant human thrombomodulin in the treatment of disseminated intravascular coagulation: A systematic review and meta-analysis	10
Platelets in pregnancy - protector or adversary?	10
COVID-19 associated Venous Thromboembolism (VTE) burden in Black women: Findings of Veterans Affairs COVID-19 Shared Data	10
Letter to the editor regarding ‘efficacy of Radiosynoviorthesis on clinical outcomes in persons with haemophilia. A systematic review and meta-analysis’	10
Natural history of untreated acute pulmonary embolism in patients with cancer: A retrospective cohort of missed pulmonary emboli	10
Editorial Board	10
Tissue factor expression in monocyte subsets during human immunothrombosis, endotoxemia and sepsis	10
Editorial Board	10
JAK2V617F-positive extracellular genomic materials drive endothelial inflammation and thrombosis in myeloproliferative neoplasms	9
The differential formation and composition of leukocyte-platelet aggregates induced by various cellular stimulants	9
Anti-Xa Levels with Venous Thromboembolism Prophylaxis in Critical Care: A Systematic Review and Meta-Analysis	9
To clot, or not to clot: The dilemma of hormone treatment options for menopause	9
Health-related quality of life associated with warfarin and direct oral anticoagulants in venous thromboembolism	9
Anticoagulation with argatroban using hemoclot™ targets is safe and effective in CARDS patients receiving venovenous extracorporeal membrane oxygenation: An exploratory bi-centric cohort study	9
Long term recovery of right ventricular function after treatment of intermediate and high risk pulmonary emboli	9
Effectiveness and safety of anticoagulants among venous thromboembolism cancer patients with and without brain cancer	9
Disulfide bond control of platelet αIIbβ3 integrin	9
Development and validation of a clinical prediction model for post thrombotic syndrome following anticoagulant therapy for acute deep venous thrombosis	9
Venous thromboembolism prevention in ambulatory oncology: A multi-method evaluation of the Vermont Model to inform adaptation to an oncology-delivered model	9
Dielectric blood coagulometry to evaluate coagulation activity in patients prescribed factor Xa inhibitors undergoing elective surgery: A prospective observational study	9
Thrombectomy in high-risk pulmonary embolism – device versus thrombolysis: rationale and design of the TORPEDO-NL investigator-initiated, academically-sponsored, multicenter, open-label randomized con	9
Defibrotide mitigates endothelial cell injury induced by plasmas from patients with COVID-19 and related vasculopathies	9
Depression and anxiety up to two years after acute pulmonary embolism: Prevalence and predictors	9
Anticoagulation therapy vs clinical surveillance in isolated subsegmental pulmonary embolism: a systematic review and meta-analysis	9
Exploration of rotational thromboelastometry (ROTEM) to characterize the coagulation profiles of newly diagnosed pediatric leukemia patients	9
Cold exposure promotes thrombotic risk in ischemic stroke by activating the platelet cGAS-STING pathway	9
Management options for pediatric venous thromboembolic disease: Beyond anticoagulation with endovascular therapies	9
Early immune tolerance induction is a unique predictor of favorable outcomes in hemophilia A children with intron 22 inversion and high-responding inhibitors	9
Evaluation of patient experiences with a structured home treatment pathway for pulmonary embolism using direct oral anticoagulants	9
The efficacy and safety of andexanet alfa in the treatment of anticoagulation-related major bleedings: An Italian perspective	9
Patients with multiple myeloma and monoclonal gammopathy of undetermined significance have variably increased thrombin generation and different sensitivity to the anticoagulant effect of activated pro	9
SARS-CoV-2 infection, vaccination and acquired hemophilia: Correspondence	8
Acquired factor XI deficiency in paediatrics patients: A French series and review of literature cases	8
Prevalence of antiphospholipid antibody syndrome misclassification in an academic health system	8
20-HETE induced platelet activation via a GPR75-independent pathway	8
D-dimer to fibrinogen ratio predicts early neurological deterioration in ischemic stroke with atrial fibrillation	8
Hemostatic alterations in metabolic dysfunction-associated steatotic liver disease (MASLD) and their link to venous thromboembolism (VTE)	8
The heat shock protein DNAJB2 as a novel biomarker for essential thrombocythemia diagnosis associated with immune infiltration	8
Exploring anti-Xa activity and its correlation with C-Reactive Protein in Intensive Care Unit patients receiving a therapeutic dosage of nadroparin	8
Panel of genetic risk markers for prediction of susceptibility towards venous thromboembolism (VTE)	8
Differential prognosis of patients that are candidates for standard, short or prolonged dual antiplatelet treatment discharged after an acute coronary syndrome	8
Chemotherapy alters thrombomodulin and factor VIIIc expression resulting in acquired activated protein C resistance and enhanced thrombin generation in cancer associated thrombosis	8
Treatment patterns and outcomes of second-line rituximab and thrombopoietin receptor agonists in adult immune thrombocytopenia: A Canadian retrospective cohort study	8
Phenotype, genotype, and laboratory assessment of congenital fibrinogen disorders: Data from the Rare Bleeding disorders in the Netherlands study	8
Modest performance of risk-prediction models for anticoagulant-related bleeding in patients with chronic liver disease	8
Efficacy and safety of prophylaxis and treatment of bleeding events with a novel fibrinogen concentrate from human plasma in patients with congenital fibrinogen deficiency	8
Platelet and endothelial cell activation in antiretroviral therapy-treated African women living with HIV and obesity	8
Antiplatelet and anticoagulant therapies in hereditary hemorrhagic telangiectasia: A large French cohort study (RETROPLACOTEL)	8
Prothrombotic plasma fibrin clot phenotype is associated with spontaneous echo contrast in atrial fibrillation: The role of protein carbonylation	8
Isocitrate dehydrogenase mutation and risk of venous thromboembolism in glioma: A systematic review and meta-analysis	8
Additive effect of factor X on the structure and stability of activated factor VII-induced fibrin clot in hemophilic plasma with inhibitor	8
Influence of primary cancer site on clinical outcomes of anticoagulation for associated venous thromboembolism	8
Combined exome and RNA-seq analysis in patients with rare non-syndromic inherited brain arteriovenous malformation suggests a novel function for PTPN13 in arterial specification	8
Blood group non-O is not associated with long-term adverse outcomes in patients undergoing percutaneous coronary intervention	8
Techniques for measuring NETosis: A critical literature review and outlook for standardization	8
Subject: Letter to the editor regarding the article “A systematic review on the effects of direct oral anticoagulants on cancer growth and metastasis in animal models”	8
Major cardiovascular events after COVID-19, event rates post-vaccination, antiviral or anti-inflammatory therapy, and temporal trends: Rationale and methodology of the CORONA-VTE-Network study	8
Risk of thromboembolism according to statin treatment in patients with cancer: A nationwide nested case-control study	8
Apixaban thromboprophylaxis in ambulatory patients with cancer and obesity: Insights from the AVERT trial	8
Oral anticoagulants and cognitive impairment in patients with atrial fibrillation: A systematic review with meta-analysis and trial sequential analysis	8
Prognostic significance of saddle pulmonary embolism a post hoc analysis of the PROTECT cohort study	8
Prothrombin complex concentrate for direct factor Xa inhibitor-associated bleeding or before urgent surgery	8
Epigenetic repression of THBD transcription by BRG1 contributes to deep vein thrombosis	8
Risk of bleeding in pulmonary embolism patients concomitant with COVID-19 undergoing extended anticoagulation: A multicenter cohort study	8
Prolonged duration of pharmacological thromboprophylaxis following oncologic surgery: A systematic review and meta-analysis of RCTs	8
Anticoagulation stewardship in the ambulatory settings of long-term care and rehabilitation - A multi-centric descriptive pilot study	8
Response to letter to the editor	8
Late venous thromboembolism in survivors of adolescent and young adult cancer: A population-based study in California	8
Clinical prediction tool to identify children at risk of pulmonary embolism	8
Structure and pharmacokinetics/pharmacodynamics of the anticoagulant tetradecasaccharide oHG-14 as an intrinsic tenase inhibitor	7
Disseminated intravascular coagulation with hyperfibrinolysis induced by a degenerating uterine leiomyoma: A rare case report	7
White blood cell subtypes and neutrophil extracellular traps as biomarkers for stroke etiology	7
Tissue factor in COVID-19-associated coagulopathy	7
The post-VTE functional status scale for assessment of functional limitations in patients with venous thromboembolism: Construct validity and responsiveness in a prospective cohort study	7
Gene variants in a family with inherited coagulation factor XI deficiency and identification of novel mutations	7